- Home
- Publications
- Publication Search
- Publication Details
Title
The Coming Era of Quadrivalent Human Influenza Vaccines
Authors
Keywords
-
Journal
DRUGS
Volume 72, Issue 17, Pages 2177-2185
Publisher
Springer Nature
Online
2012-10-31
DOI
10.2165/11641110-000000000-00000
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Myocardial Injury and Bacterial Pneumonia Contribute to the Pathogenesis of Fatal Influenza B Virus Infection
- (2012) Christopher D. Paddock et al. JOURNAL OF INFECTIOUS DISEASES
- Immunogenicity and Safety of a Quadrivalent Live Attenuated Influenza Vaccine in Children
- (2012) Stan L. Block et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Public health impact of including two lineages of influenza B in a quadrivalent seasonal influenza vaccine
- (2012) Carrie Reed et al. VACCINE
- The rationale for quadrivalent influenza vaccines
- (2012) Christopher S. Ambrose et al. Human Vaccines & Immunotherapeutics
- Severe influenza cases in paediatric intensive care units in Germany during the pre-pandemic seasons 2005 to 2008
- (2011) Andrea Streng et al. BMC INFECTIOUS DISEASES
- Prevalence of Antibodies against Seasonal Influenza A and B Viruses in Children in Netherlands
- (2011) R. Bodewes et al. Clinical and Vaccine Immunology
- Clinical manifestations and socio-economic impact of influenza among healthy children in the community
- (2011) Susanna Esposito et al. JOURNAL OF INFECTION
- Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis
- (2011) Michael T Osterholm et al. LANCET INFECTIOUS DISEASES
- A randomized, double-blind noninferiority study of quadrivalent live attenuated influenza vaccine in adults
- (2011) Stan L. Block et al. VACCINE
- Protective efficacy of a trivalent recombinant hemagglutinin protein vaccine (FluBlok®) against influenza in healthy adults: A randomized, placebo-controlled trial
- (2011) John J. Treanor et al. VACCINE
- Trivalent and quadrivalent MF59®-adjuvanted influenza vaccine in young children: A dose- and schedule-finding study
- (2011) Giovanni Della Cioppa et al. VACCINE
- Clinical Efficacy of Cell Culture–Derived and Egg‐Derived Inactivated Subunit Influenza Vaccines in Healthy Adults
- (2010) Sharon Frey et al. CLINICAL INFECTIOUS DISEASES
- Preclinical and Clinical Development of Plant-Made Virus-Like Particle Vaccine against Avian H5N1 Influenza
- (2010) Nathalie Landry et al. PLoS One
- Global production of seasonal and pandemic (H1N1) influenza vaccines in 2009–2010 and comparison with previous estimates and global action plan targets
- (2010) Jeffrey Partridge et al. VACCINE
- Safety and immunogenicity of a recombinant hemagglutinin influenza–flagellin fusion vaccine (VAX125) in healthy young adults
- (2010) John J. Treanor et al. VACCINE
- Long-term immunogenicity of influenza vaccine among the elderly: Risk factors for poor immune response and persistence
- (2010) Joon Young Song et al. VACCINE
- Challenge of conducting a placebo-controlled randomized efficacy study for influenza vaccine in a season with low attack rate and a mismatched vaccine B strain: a concrete example
- (2009) Jiří Beran et al. BMC INFECTIOUS DISEASES
- Efficacy of live attenuated influenza vaccine in children against influenza B viruses by lineage and antigenic similarity
- (2009) Robert B. Belshe et al. VACCINE
- Influenza-Associated Pediatric Mortality in the United States: Increase of Staphylococcus aureus Coinfection
- (2008) L. Finelli et al. PEDIATRICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now